Center For Cognitive Medicine
-
Biomedical engineer awarded $1.1M to study molecular underpinnings of human brain networks on a large scale
Mikail Rubinov, assistant professor of biomedical engineering, computer science, psychiatry and psychology, has been awarded a four-year, $1.1 million grant from the National Institute of Mental Health to better understand the development and organization of brain networks, as well as their change in development and aging. Read MoreMar 17, 2022
-
Brain circuits in schizophrenia
Vanderbilt psychiatrists are probing brain circuit hyperactivity implicated in schizophrenia, with the idea that normalizing the hyperactivity may improve cognitive processes. Read MoreSep 20, 2021
-
Mood and cognition after chemotherapy
Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report. Read MoreJul 26, 2021
-
Pinpointing brain changes in psychosis
Specific regions of the thalamus — a central brain region — are smaller in adults with psychotic disorders and youth at risk for psychotic disorders and are associated with cognitive impairment. Read MoreOct 1, 2020
-
Turning Heads: The Vanderbilt Brain Institute has emerged as a hub of discovery as neuroscience’s influence expands
The VBI recently marked its 20th anniversary, a span that has seen the institute’s wide-ranging missions—including administering the university’s Neuroscience Graduate Program, as well as postdoctoral training and community outreach—steadily coalesce under a single umbrella. Read MoreAug 5, 2020
-
Committed to Memory: VU319 may hold the key to improving memory loss in Alzheimer’s patients
VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease. Read MoreJul 23, 2020
-
How proteins spread linked to Alzheimer’s disease sex differences
The ways certain proteins spread may help explain why the prevalence of Alzheimer’s is higher in women than in men. Read MoreJul 18, 2019
-
Free memory and Alzheimer’s gene screenings May 14
Staff from the Center for Cognitive Medicine will administer memory screenings and Alzheimer’s gene screenings at no cost to community members ages 60 and above. Read MoreMay 10, 2019
-
Center for Cognitive Medicine offering Alzheimer’s APOE4 Gene Screening
Center for Cognitive Medicine offering Alzheimer's APOE4 Gene Screening at Whole Foods on Feb. 18. Read MoreFeb 12, 2019
-
Volunteers needed for study exploring Alzheimer’s risk
The Center for Cognitive Medicine is seeking volunteers ages 65-75 who have not been diagnosed with any memory impairment and are interested in whether their genetics show they are at increased risk of Alzheimer’s disease. Read MoreJan 4, 2019
-
Volunteers 55-75 needed for study involving free memory screening
The Center for Cognitive Medicine is in search of volunteers ages 55-75 to participate in a free memory screening. Read MoreNov 9, 2018
-
Center for Cognitive Medicine open house and Alzheimer’s screening
Interested in the treatments and prevention of Alzheimer's disease? The Center for Cognitive Medicine is hosting an open house and screening event on Sept. 7. Read MoreSep 4, 2018
-
‘An Aging and Healthy Brain Symposium and Community Dinner’
The Center for Cognitive Medicine at Vanderbilt Univerity Medical Center presents, 'An Aging and Healthy Brain Symposium & Community Dinner' on Aug. 22. Read MoreAug 14, 2018
-
ApoE4 Alzheimer’s Gene Screening on Aug. 3
The Center for Cognitive Medicine at Vanderbilt University Medical Center in partnership with the Generation Program will be offering ApoE4 Alzheimer’s Gene Screening on Friday, August 3. Read MoreAug 1, 2018
-
Clues found to recurrent depression
Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains. Read MoreMar 2, 2017
-
Alzheimer’s risk gene in younger adults
A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age. Read MoreJun 2, 2016
-
Depression study seeks to predict treatment response
Treating depressed individuals and figuring out who will and won’t respond to antidepressants is mostly trial and error — much to the frustration of patients and the health care providers who treat them. Read MoreAug 27, 2015
-
Blood pressure gene tied to cognitive decline
Size may not matter in a lot of things, but when it comes to cognitive decline, the size of the hippocampus definitely seems to be an issue. Read MoreDec 4, 2014
-
Cancer drug enhances cognition
The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women. Read MoreDec 16, 2013
-
Estrogen treatments increase gray matter in brain
Short-term hormone replacement therapy offers potential benefit for cognitive functioning. Read MoreNov 18, 2011